Abbvie Inc
NYSE: ABBV
$175.17
-$3.33 (-1.9%)
Closing Price on January 10, 2025
ABBV Articles
The Franchise Picks list makes sense for solid growth investors looking for total return. Many of the stocks pay good dividends and have upside price potential.
Published:
Last Updated:
Tuesday's top analyst upgrades, downgrades and initiations include AbbVie, CDW, CSC, Eli Lilly, Ericsson, Gold Fields, JD.com, Nokia and Rackspace.
Published:
Last Updated:
Buying high-yielding blue chips for 2016 makes good sense. The Federal Reserve interest rate increases over the next two years are expected to remain very small and very measured.
Published:
Last Updated:
You may want to avoid these stocks over the next few months.
Published:
Last Updated:
Jefferies has updated the thesis behind its "Top 5 for 2015" pharmaceutical stock picks
Published:
Last Updated:
The short interest data have been released for the October 30 settlement date, and for most of the selected pharmaceutical stocks, short interest was down.
Published:
Last Updated:
Buying stocks such as these, with solid growth potential and paying dividends higher than the 10-year Treasury debt, makes good sense now.
Published:
Last Updated:
Tuesday's top analyst upgrades, downgrades and initiations include AbbVie, Apple, Autodesk, JD.com, CyberArk, Dean Foods and Walt Disney.
Published:
Last Updated:
AbbVie reported better-than-expected third-quarter financial results before the markets opened on Friday.
Published:
Last Updated:
AbbVie is expected to report its third-quarter financial results before the markets open on Friday.
Published:
Gilead Sciences is set to report its third-quarter financial results after the markets close on Thursday.
Published:
The October 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest was mixed.
Published:
Each week we cover the new value calls from the analysts at Jefferies, and more and more, some of the calls may look surprising.
Published:
These biotech stocks 24/7 Wall St. has picked stood out from the rest with at least 25% gains over the course of the past week.
Published:
Friday's top analyst upgrades, downgrades and initiations include AbbVie, Alphabet, Amazon.com, American Electric Power, Apple, Microsoft, Pandora Media and McDonald's.
Published:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.